311 results
Page 6 of 16
8-K
EX-99.1
nn2 9b70xj1g6ac
9 Jul 13
This presentation contains "forward-looking statements" as defined by the Private
12:00am
8-K
b45r278a5cnqjpvb
6 May 13
Unregistered Sales of Equity Securities
12:00am
424B3
rv9bwymn
28 Mar 13
Prospectus supplement
12:00am
8-K
EX-99.1
cj1pzegb1z1z5avxl
28 Mar 13
A.P. Pharma Receives FDA Complete Response Letter for APF530
12:00am
424B3
bajgddi1
28 Mar 13
Prospectus supplement
12:00am
8-K
EX-99.2
8g5fklqju5k3 p8m
5 Mar 13
A.P. Pharma Appoints Jesse Hollingsworth
12:00am
8-K
EX-99.1
u4jjo pxhx
5 Mar 13
A.P. Pharma Appoints Jesse Hollingsworth
12:00am
8-K
EX-99.1
cqcj9x1g0
7 Jan 13
This presentation contains "forward-looking statements" as defined by the Private
12:00am
8-K
EX-99.1
d3sluilrl5twomk qxnh
18 Dec 12
A.P. Pharma Makes Key Appointments in Preparation of Potential FDA Approval of Lead Product Candidate, APF530
12:00am
8-K
EX-99.1
u6k8ud vh
14 Dec 12
A.P. Pharma Names Mark S. Gelder, M.D. as Senior Vice President and Chief Medical Officer
12:00am
424B3
876 1wkqvfq28gpk3ny4
5 Nov 12
Prospectus supplement
12:00am
424B3
mt4ypfu1
5 Nov 12
Prospectus supplement
12:00am
8-K
EX-99.1
lc1ji2p63l bfbv1
5 Nov 12
A.P. Pharma Announces Third Quarter 2012 Financial Results and Highlights Recent Corporate Progress
12:00am